Given that stem cell quiescence is vital for the maintenance of CML stem cells, we used in vivo BrdU incorporation assays to evaluate the cell cycle distribution of Gdpd3-deficient and WT-CML stem cells in CML-affected mice after a first-round of BMT. The gene discussed is GDPD3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.